2020
DOI: 10.18203/2320-1770.ijrcog20203870
|View full text |Cite
|
Sign up to set email alerts
|

Gastrointestinal symptoms in COVID-19 patients: a case series

Abstract: The coronavirus disease 2019 (COVID-19) pandemic, caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), presents an ongoing global threat. Common clinical features reported in early confirmed infections included fever, cough, and myalgias or fatigue. But as testing capacity and case numbers have increased worldwide, gastrointestinal (GI) symptoms such as diarrhoea, nausea/vomiting, abdominal pain, and loss of appetite have been increasingly recognized. Authors present a case series of gas… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2021
2021
2021
2021

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 16 publications
0
1
0
Order By: Relevance
“…SARS-CoV-2, a respiratory virus, has also been shown to persist in the gastrointestinal tract as evident from its presence in the faecal samples of COVID-19 patients, who have tested positive for SARS-CoV-2 RNA [35]. Furthermore, its association with protein receptor or Angiotensin-converting enzyme 2 (ACE-2) [123,124] and release of infectious virions from the virus-infected gut through faecal discharge, in large numbers, is a worrying sign [125,126]. Studies further suggest that viral samples are extensively released into wastewater through faecal shedding and can last for longer even in those patients who have been declared PCR negative in oral & throat swabs and are not showing any COVID-19 respiratory symptoms even after a month [32,127].…”
Section: Transmission Tracking and Assessing The Burden Of Diseasementioning
confidence: 99%
“…SARS-CoV-2, a respiratory virus, has also been shown to persist in the gastrointestinal tract as evident from its presence in the faecal samples of COVID-19 patients, who have tested positive for SARS-CoV-2 RNA [35]. Furthermore, its association with protein receptor or Angiotensin-converting enzyme 2 (ACE-2) [123,124] and release of infectious virions from the virus-infected gut through faecal discharge, in large numbers, is a worrying sign [125,126]. Studies further suggest that viral samples are extensively released into wastewater through faecal shedding and can last for longer even in those patients who have been declared PCR negative in oral & throat swabs and are not showing any COVID-19 respiratory symptoms even after a month [32,127].…”
Section: Transmission Tracking and Assessing The Burden Of Diseasementioning
confidence: 99%